BANK VONTOBEL/PUT/ELI LILLY & CO/760/0.1/20.09.24 | Market Closed - Boerse Frankfurt Warrants 13:43:38 2024-07-05 EDT | ||
| 0.62 EUR | -26.19% |
|
| Current month | -6.06% | ||
| 1 month | -68.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 0.62 | -26.19% |
| 24-07-04 | 0.84 | -3.45% |
| 24-07-03 | 0.87 | +14.47% |
| 24-07-02 | 0.76 | +26.67% |
| 24-07-01 | 0.6 | -9.09% |
Real-time Boerse Frankfurt Warrants
Last update July 05, 2024 at 01:43 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Vontobel
|
| WKN | VD0FGY |
| ISIN | DE000VD0FGY5 |
| Date issued | 2024-02-15 |
| Strike | 760 $ |
| Maturity | 2024-09-20 (77 Days) |
| Parity | 10 : 1 |
| Emission price | 5.49 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.29 € |
|---|---|
| Lowest since issue | 0.6 € |
| Spread | 0.02 € |
| Spread % | 3.23% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
898.1
USD
Average target price
870.3
USD
Spread / Average Target
-3.10%
- Stock Market
- Warrants
- Warrant
